ABOUT US
TECHNOLOGY
PIPELINE
CAREERS
PR
KOR
ENG
PR
Press release
Promotion
Notice
MaxCyte Signs Strategic Platform License with Curamys to Enable Cell & Gene Therapies for the Treatment of Rare Intractable Diseases
2022.12.05
"We will overcome intractable Lou Gehrig's disease & Duchenne disease."
2020.01.22
TOP
TOP